Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging
Phase of Trial: Phase IV
Latest Information Update: 20 Sep 2018
Price : $35 *
At a glance
- Drugs Regadenoson (Primary)
- Indications Coronary artery disease
- Focus Diagnostic use
- 30 May 2018 Status changed from recruiting to completed.
- 06 Mar 2018 Planned End Date changed from 1 Feb 2018 to 1 Mar 2018.
- 09 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.